Warning letter
Creative Medical Corporation: warning letter of Feb 20, 2001
FDA warning letter UCM069339 · San Juan District Office
Key facts
| Reference number | UCM069339 |
|---|---|
| Company | Creative Medical Corporation |
| Subject | CGMP for Finished Pharmaceuticals/OTC Drug & Dietary Supplement/Adulterated |
| Issue date | Feb 20, 2001 |
| Posted date | Feb 20, 2001 |
| Issuing office | San Juan District Office |
| Product type | Drugs |
| CFR sections cited | 21, 211, 211.84, 211.160, 211.192, 211.22(a) |
| Country | 3 |
| Inspection city | Cidra |
| Inspection ZIP | 00739 |
| Inspection start date | Nov 28, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- NAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: